Previous studies found that Martrilin-3 (MATN3) was abnormally expressed and associated with the prognosis of GC (42, 43), and recent studies also confirmed the diagnostic and prognostic value of MATN3 for GC from comprehensive data mining (44, 45). The gene discussed is MATN3; the disease is gastric cancer.